Panacea Biotec Limited
NSE: PANACEABIO.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Rajesh Jain
- Employees
- 1,936
- Headquarters
- New Delhi, India
- IPO year
- 2002
- Market cap
- ₹23.8B
- Website
- https://www.panaceabiotec.com
Loading PANACEABIO…
Loading profile data…Frequently asked questions about PANACEABIO
What does Panacea Biotec Limited (PANACEABIO.NS) do?
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management,...
Where does PANACEABIO.NS trade?
Panacea Biotec Limited (PANACEABIO.NS) trades on the National Stock Exchange of India.
What sector is PANACEABIO.NS in?
Panacea Biotec Limited (PANACEABIO.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Panacea Biotec Limited?
Rajesh Jain is the chief executive officer of Panacea Biotec Limited (PANACEABIO.NS).
Where is Panacea Biotec Limited headquartered?
Panacea Biotec Limited is headquartered in India.
Does PANACEABIO.NS pay a dividend?
Panacea Biotec Limited (PANACEABIO.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PANACEABIO.NS go public?
Panacea Biotec Limited (PANACEABIO.NS) completed its initial public offering in 2002.